Picrasidine I

CAS No. 100234-59-1

Picrasidine I( —— )

Catalog No. M30839 CAS No. 100234-59-1

Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1728 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Picrasidine I
  • Note
    Research use only, not for human use.
  • Brief Description
    Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.
  • Description
    Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100234-59-1
  • Formula Weight
    240.3
  • Molecular Formula
    C14H12N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • H-Ala-Gly-Ser-Glu-OH

    H-Ala-Gly-Ser-Glu-OH

  • 8-Epideoxyloganic ac...

    8-Epideoxyloganic acid possesses bioactivities of analgesia, homeostasis and anti-inflammatory. It has the potential to serve as anti-inflammatory agents during oxidative stress, the inhibition of ROS production, possibly through modulation of NOX activity and/or the radical scavenging effect, and beta2 integrin expression in leucocytes.

  • HTBA

    HTBA is a low-cost enzymatic paper-based analytical device (enz-PAD) for determining urine creatinine.